Best Adaptogens For Stress Ashwagandha Rhodiola Comparison: Evidence-Based Guide

Quick Answer

Ashwagandha and Rhodiola both demonstrate efficacy in stress reduction, with Ashwagandha showing a 38.6% to 41.6% reduction in stress scores over 60 days, while specific metrics for Rhodiola are not provided in the current sources.

Key Takeaways

• Ashwagandha reduced Perceived Stress Scale scores by 38.6% and 41.6% in two groups over 60 days (n=135) [Source 2].
• Serum cortisol levels significantly decreased in the Ashwagandha group by the end of the study (p<0.001) [Source 2].
• Rhodiola's specific efficacy metrics are not detailed in the provided sources, indicating a gap in the current data.
• The Ashwagandha study involved 126 subjects completing the trial, indicating a robust sample size [Source 2].
• Limitations include a lack of direct comparative data between Ashwagandha and Rhodiola in the provided sources.

Clinical Evidence Deep-Dive

The study on Ashwagandha involved a randomized, double-blind, placebo-controlled trial with 135 participants, of which 126 completed the trial. Participants were divided into three groups, receiving either 150 mg or 300 mg of Ashwagandha or a placebo. The Perceived Stress Scale was used to measure stress levels, and results showed a significant reduction in stress scores by 38.6% and 41.6% in the Ashwagandha groups compared to baseline (p<0.001) [Source 2]. Additionally, serum cortisol levels, a biomarker for stress, were significantly reduced in the group receiving 300 mg of Ashwagandha, further supporting its efficacy in stress management [Source 2].

The absence of direct data on Rhodiola in the provided sources limits the ability to directly compare its efficacy to Ashwagandha. However, existing literature outside the provided sources often cites Rhodiola as beneficial for stress reduction, though specific metrics and study designs are necessary for a comprehensive comparison.

The Ashwagandha study's robust methodology, including its sample size and control measures, lends moderate confidence to its findings. However, the lack of direct comparative trials with Rhodiola suggests that further research is needed to establish a definitive efficacy hierarchy between these adaptogens.

Practical Protocol

Clinical reference - consult a physician: Ashwagandha was administered in doses of 150 mg and 300 mg daily over 60 days in the study, with both doses showing significant stress reduction [Source 2]. Dosage for Rhodiola is not specified in the provided sources, necessitating consultation with healthcare providers for personalized recommendations.

FAQ

Does Ashwagandha reduce cortisol levels? Yes, the study showed a significant reduction in serum cortisol levels in participants taking 300 mg of Ashwagandha daily [Source 2].

Is Rhodiola effective for stress? While Rhodiola is commonly cited for stress reduction, specific efficacy data is not provided in the current sources, indicating a need for further research.

What are the side effects of Ashwagandha? The study did not detail side effects, but clinical trials often report mild gastrointestinal symptoms. Consulting a healthcare provider is recommended for personalized advice.

References

[1] The Effect of Progressive Relaxation Exercises Applied to Individuals With Type 2 Diabetes on FATIQUE Level and Sleep Quality: A Randomised Controlled Study. Vardar Inkaya B. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13053216/

[2] Efficacy and safety of Ashwagandha root extract sustained-release (AshwaSR) capsules in healthy adult, stressed subjects: A randomized, double-blind, placebo-controlled, parallel-group, 3-arm clinical trial. Thanawala Shefali. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12991725/

[3] Nursing Pillows in the Sleep Environment and Sudden Unexpected Infant Deaths — Georgia, January 2013–December 2022. DEPUTY DIRECTOR FOR PUBLIC HEALTH SCIENCE AND SURVEILLANCE. 2025. https://www.cdc.gov/mmwr/volumes/74/wr/mm7419a2.htm

[4] Notes from the Field: Rhodesiense Human African Trypanosomiasis (Sleeping Sickness) in a Traveler Returning from Zimbabwe — United States, August 2024. DEPUTY DIRECTOR FOR PUBLIC HEALTH SCIENCE AND SURVEILLANCE. 2025. https://www.cdc.gov/mmwr/volumes/74/wr/mm7409a3.htm

[5] Clinical Care Interaction and Patient Sleep in the Intensive Care Unit: A Secondary Data Analysis. Islam A. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13071779/